Taken together, these data suggest that EA could significantly change the temporal and spatial distribution of A20 in the cerebral ischemia/reperfusion area and confirmed that EA is an effective method to rapidly upregulate A20 expression. The gene discussed is TNFAIP3; the disease is brain ischemia.